Pharmaceutical Major Johnson & Johnson said it has paid Rs 25 lakh each to three victims of its faulty acetabular surface replacement (ASR) hip implants in Uttar Pradesh. According to Uttar Pradesh Drug Licensing and Control officer A K Jain, the company has given compensation to three patients who had undergone revision surgeries for the faulty implants made by the company. The Delhi High Court had in May directed Johnson and Johnson to make an interim payment of Rs 25 lakh each to the 67 patients who have undergone revision surgeries. Jain said the Uttar Pradesh Drug Licensing and Control Authority was promptly following such complaints.
from Companies https://ift.tt/33Ug10q
via IFTTT
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
India is the largest market by users for both Facebook and its messenger service WhatsApp from Home Page https://ift.tt/3aUtevW via IFTTT...
-
The Finance Industry Development Council (FIDC) has urged the Ministry of Micro, Small & Medium Enterprises (MSME) to address issues fac...
-
India has started exporting cereals like rice and wheat to new destinations, including Puerto Rico, Yemen and Poland, with a view to push ag...
No comments:
Post a Comment